Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05303519 |
| Title | Safusidenib Phase 2 Study in IDH1 Mutant Glioma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | AnHeart Therapeutics Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | United States | Details | |
| Massachusetts General Hospital | Boston | Massachusetts | 02214 | United States | Details | |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Columbia University Medical Center | New York | New York | 10032 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| Duke Cancer Institute | Durham | North Carolina | 27710 | United States | Details | |
| Cleveland Clinic | Cleveland | Ohio | 44106 | United States | Details | |
| Huntsman Cancer Insititute, University of Utah | Salt Lake City | Utah | 84112 | United States | Details | |
| UVA Health, Emily Couric Clinical Cancer Cente | Charlottesville | Virginia | 22903 | United States | Details |